Pancreatic Cancer Clinical Trials
There are 33 registered clinical trials for Pancreatic Cancer in the TrialLens index.
Trials (33)
- Chemotherapy With or Without Dalteparin in Treating Patients With Metastatic Pancreatic Cancer Phase 3 · GERCOR - Multidisciplinary Oncology Cooperative Group
- A Study of ARRY-334543 and Gemcitabine in Patients With Advanced Cancer and Pancreatic Cancer Phase 1/2 · Array BioPharma
- Endoscopic Stenting Versus Surgical Bypass for Low Bile Duct Obstruction by Cancer of the Pancreatic Head N/A · Heidelberg University
- Supportive Oncology Care At Home RCT N/A · Massachusetts General Hospital
- Early Increase in Blood Flow (EIBS) in the Duodenum in Patients With Pancreatic Cancer N/A · Mayo Clinic
- Exercise to Reduce Chemotherapy-Induced Peripheral Neuropathy N/A · University of Michigan Rogel Cancer Center
- The Characteristics of Oral Microbiota in Chronic Pancreatitis and Autoimmune Pancreatitis N/A · Ruijin Hospital
- Second-line Irinotecan Liposome Combination Regimen for Irinotecan-treated Pancreatic Cancer Phase 2 · Rui-hua Xu, MD, PhD
- Endoscopic Ultrasound-guided Biliary Drainage for Malignant Biliary Obstruction After Failed ERCP N/A · Azienda USL Reggio Emilia - IRCCS
- SBRT Plus Pembrolizumab and Trametinib for Pancreatic Cancer Phase 2 · Changhai Hospital
- Gemcitabine, Capecitabine, and Bevacizumab in Treating Patients With Metastatic or Unresectable Pancreatic Cancer Phase 2 · Roswell Park Cancer Institute
- The Role of the Tumor Microenvironment of Pancreatic Cancer to Predict Treatment Outcome N/A · Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
- Gemcitabine, 5-Fluorouracil, and Radiation Therapy in the Treatment of Non-Metastatic Pancreatic Cancer Phase 1 · Dana-Farber Cancer Institute
- Safety and Efficacy of CEA-Targeted CAR-T Therapy for Relapsed/Refractory CEA+ Cancer Phase 1/2 · Chongqing Precision Biotech Co., Ltd
- Efficacy of Neoadjuvant Chemoradiation for Potentially Resectable Pancreas Cancer Phase 2 · Amer Zureikat
- A Clinical Study of UFT/Leucovorin, Radiotherapy With or Without Cetuximab Following Induction Gemcitabine Plus Capecitabine in Patients With Locally Advanced Pancreatic Cancer (PERU) Phase 2 · Royal Marsden NHS Foundation Trust
- The Efficacy and Safety of K-001 in the Treatment of Advanced Pancreatic Cancer Phase 2/3 · RenJi Hospital
- Combination of Icotinib and Gemcitabine as First-line Treatment in Pancreatic Cancer Phase 1 · Betta Pharmaceuticals Co., Ltd.
- A Multicenter Prospective Randomized Controlled Study of RPD Versus LPD N/A · The First Affiliated Hospital of University of South China
- Gemcitabine and Bevacizumab in Treating Patients With Pancreatic Cancer That Has Been Completely Removed By Surgery Phase 1/2 · University of California, San Francisco
- Tissue Pharmacokinetics of Intraoperative Gemcitabine in Resectable Adenocarcinoma of the Pancreas Early Phase 1 · M.D. Anderson Cancer Center
- Pancreatic and Gastrointestinal Tumor Registry and Tissue Collection N/A · University of Alabama at Birmingham
- Study of Gemcitabine, Abraxane® Plus Placebo Versus Gemcitabine, Abraxane® Plus 1 or 2 Truncated Courses of Demcizumab in Subjects With 1st-Line Metastatic Pancreatic Ductal Adenocarcinoma Phase 2 · OncoMed Pharmaceuticals, Inc.
- FOLFIRINOX Plus IPI-926 for Advanced Pancreatic Adenocarcinoma Phase 1 · Andrew Ko
- High Dose-Rate Brachytherapy for the Treatment of Both Primary and Secondary Unresectable Liver Malignancies N/A · M.D. Anderson Cancer Center
- Feasibility of the Loop Brush EUS-FNA for Characterization of Pancreatic Cysts: Pilot Clinical Investigation N/A · Urban Arnelo
- 18F-T2 PET/CT Imaging for CAIX Positive Solid Tumors N/A · Peking University First Hospital
- Intravenous Lidocaine for Pain Associated With Pancreatic Cancer and Chronic Pancreatitis Phase 2 · Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
- Pemetrexed, Gemcitabine, and Radiation Therapy in Treating Patients With Locally Advanced Pancreatic Cancer Phase 1 · Wake Forest University Health Sciences
- Boost GVAX Pancreas Vaccine With or Without CY in Patients With Pancreas Cancer Phase 2 · Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
- EUS Examination Using EndoSound Vision System vs. Standard Echoendoscope N/A · Orlando Health, Inc.
- Protocol for High-Risk Assessment, Screening, and Early Detection of Pancreatic Cancer N/A · H. Lee Moffitt Cancer Center and Research Institute
- Vorinostat Plus Radiation Therapy in Pancreatic Cancer Phase 1/2 · M.D. Anderson Cancer Center
Related landscapes
- Phase 1/2 Pancreatic Cancer
- Phase 2 Pancreatic Cancer
- Phase 3 Pancreatic Cancer
- N/A Pancreatic Cancer
- Phase 2/3 Pancreatic Cancer
Trial data from ClinicalTrials.gov (U.S. public domain) and ISRCTN (CC BY 4.0), used with attribution. TrialLens is an independent index, not affiliated with or endorsed by ClinicalTrials.gov, the NIH, or any trial sponsor. For research only — not medical advice.